Australia's EchoIQ soars to near 15-year high after Pro Medicus deal
25/06/2026 04:22
BUZZ-Australia's EchoIQ soars to near 15-year high after Pro Medicus deal ** EchoIQ's shares EIQ.AX gain as much as 51.2% to A$1.875, their highest level since August 3, 2011
** Medtech firm says it signed an agreement with health imaging firm Pro Medicus PME.AX for strategic investment and U.S. commercial partnership
** PME to invest an initial A$10 million ($6.89 million), with an option to invest further A$10 million following U.S. FDA clearance of EchoSolv HF, an AI-driven clinical decision support software - co
** PME to become a proposed reseller of EchoSolv, subject to entry into definitive agreements - EIQ
** Around 11.3 mln shares traded so far, nearly 4.6x 30-day average
** EIQ up more than 500% YTD
($1 = 1.4507 Australian dollars)
(Reporting by Keshav Singh Chundawat in Bengaluru)
Recent news on EchoIQ
See all newsAustralia's EchoIQ gains most in nearly 3 months after FDA update
Brief: EchoIQ Says FDA Raises No Concerns About Echosolv HF Technology Or Core Functionality
Australia's EchoIQ heads for worst week in seven years after US FDA setback
Australia's Echo IQ logs worst day in seven years after FDA setback
Brief: EchoIQ Requests Trading Halt